PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

#marketaccess

Tag

Posts navigation

1 2 Next
MHRA consults on ending EC Decision Reliance Procedure

MHRA consults on ending EC Decision Reliance Procedure

The Medicines and Healthcare products Regulatory Agency (MHRA) is inviting feedback on plans to end use of the European Commission Decision Reliance Procedure (ECDRP) to bring medicines to market.

4 Sep 2023
Read More
MHRA publishes annual report for 2022-2023

MHRA publishes annual report for 2022-2023

The UK Medicines and Healthcare products Regulatory Agency’s (MHRA) annual report and accounts for 2022-2023 was printed on 19 July 2023. The report outlines achievements during the year, such as its evolution into a ‘One Agency’ organisation, uniting its regulatory, research and standards and clinical data service.

31 Jul 2023
Read More
Pharma organisations tussle over VPAS negotiations

Pharma organisations tussle over VPAS negotiations

A High Court judgment on a judicial review brought by the British Generic Manufacturers Association (BGMA) has dismissed the organisation’s claim that it was unfairly excluded from talks on the next Voluntary Scheme for Branded Medicines Pricing and Access (VPAS).

20 Jul 2023
Read More
MHRA announces corporate plan for 2023-2026

MHRA announces corporate plan for 2023-2026

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has published its corporate plan for the next three years, featuring a focus on patient access to innovation.

17 Jul 2023
Read More
Pharma conference examines MHRA, VPAS, staffing and real estate needs

Pharma conference examines MHRA, VPAS, staffing and real estate needs

Four important themes for the life sciences were the focus of the Professional Industry Network Group (PING) conference, held in June 2023. These included the position of the Medicines and Healthcare products Regulatory Agency (MHRA) post the COVID-19 pandemic, the implications of the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) and the proposed Voluntary Scheme for Pricing, Access and Growth (VPAG), plus whether there were adequate staffing and premises to support the sector.

4 Jul 2023
Read More
EFPIA calls for revisions to Pharmaceutical Regulation

EFPIA calls for revisions to Pharmaceutical Regulation

The leaders of the European Federation of Pharmaceutical Industries and Associations (EFPIA) have warned that the proposed reforms to the European Commission’s (EC) Pharmaceutical Legislation should be revised as they believe they risk damaging Europe’s capacity for innovation and international competitiveness.

28 Jun 2023
Read More
The O’Shaughnessy report: how to boost clinical trials in the UK

The O’Shaughnessy report: how to boost clinical trials in the UK

The much anticipated O’Shaughnessy report examining commercial clinical trials in the UK was published at the end of May 2023. Its findings have prompted the UK government to initiate a series of actions, in response to its 27 recommendations, that are designed to make the UK a world leader in this important part of the life sciences industry.

26 Jun 2023
Read More
New drug costs threaten NHS financial stability, says report

New drug costs threaten NHS financial stability, says report

The new report, ‘Promoting population health through pharmaceutical policy: The role of the UK Voluntary Scheme’, produced by researchers at the London School of Economics, London School of Hygiene & Tropical Medicine (LSHTM) and University of York, investigates the costs of prescription medicines to the NHS in England.

21 Jun 2023
Read More
Windsor Framework measures start 1 January 2025

Windsor Framework measures start 1 January 2025

The government has announced that new measures laid out in the Windsor Framework regarding the supply of medicines to Northern Ireland will commence from 1 January 2025. This extends the previous deadline for compliance, which was 31 December 2023.

19 Jun 2023
Read More
MHRA announces international partnerships to accelerate medicines approvals

MHRA announces international partnerships to accelerate medicines approvals

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced a new international framework that will help bring new medicines to patients faster.

8 Jun 2023
Read More

Posts navigation

1 2 Next

Categories

  • Awards
  • Consultants
  • Events
  • News
    • General
    • Medical Affairs
    • Rare diseases
  • Our Services
  • Regulatory
  • Resources
    • White Paper

Tags

#ABPI #BIA #cancer #ClinicalTrials #drugapprovals #drugpricing #drugregulation #EC #EFPIA #EMA #EU #FDA #HorizonEurope #HTA #innovation #lifesciences #marketaccess #MDR #medicalaffairs #medicaldevice #medicinesaccess #medtech #mentalhealth #mhra #NHS #NICE #patients #pharmaregulation #pre-eclampsia #R&D #rarediseases #regulation #regulatory #research #startups #UKgovernment #ukpharma #ukregulation #VPAS AI Biotech COVID-19 Healthcare medicaldevices Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital